Clinical Risk Score (CRS) of Zheng et al for Recurrence of an Hepatocellular Carcinoma

Description

Zheng et al estimated the risk of recurrence for an hepatocellular carcinoma using a clinical risk score. This can help to identify a patient who may benefit from liver transplantation. The authors are from multiple institutions from around the would.

Patient: hepatocellular carcinoma

Outcome: risk of recurrence after resection

Parameters:

(1) preoperative disease status relative to Milan criteria

(2) number of tumor nodules

(3) microvascular invasion

Parameter	Finding	Points
preoperative status	within Milan criteria	0
	beyond Milan criteria	1
number of tumor nodules	1	0
	>= 2 (multinodular or satellites)	1
microvascular invasion	absent	0
	present	1

total score =

= SUM(points for all 3 parameters)

Interpretation:

• minimum score: 0

• maximum score: 3

• The higher the score the greater the risk of recurrence.

Total Score	5-Year Recurrence
0	19%
1	34%
2	49%
3	67%

To read more or access our algorithms and calculators, please log in or register.

Clinical Risk Score (CRS) of Zheng et al for Recurrence of an Hepatocellular Carcinoma

Description

Specialty